Trials for Type 1

Auto-Calibration Study

  • Auto-Calibration and Shaped Insulin Delivery

    ​This study aims to collect high quality glycemic information from persons with type 1 diabetes using meal challenges.

Type 1
Glucose Control

EXTEND

  • Preserving Beta-cell Function with Tocilizumab in New Onset Type 1 Diabetes

    This study is designed to test if the drug tocilizumab can help preserve or delay destruction of remaining beta cells in people recently diagnosed with type 1 diabetes.

Glucose Control
Type 1

Precision Study

  • Evaluating the accuracy of the LabPatch Continuous Glucose Monitoring system (CGM)

    ​This study is evaluating the accuracy of an investigational device (not FDA approved yet) called LabPatch Continuous Glucose Monitor by comparing it to a laboratory glucose analyser called YSI, and 2 commercial glucose meters.

Glucose Control
Technology

SENCE Study

  • Strategies to Enhance New CGM use in Early Childhood (SENCE)

    ​A clinical trial to find out how well the continuous glucose monitor works in children less than 8 years old with T1D and whether an added program for parents/guardians can improve comfort with using the CGM and improve blood glucose control.

Glucose Control
Type 1

T1GER Study

  • SIMPONI® to Arrest Beta-Cell Loss in Type 1 Diabetes

    This study aims to determine if the drug SIMPONI® (golimumab) can preserve beta-cell function in children and young adults with newly diagnosed type 1 diabetes.

Type 1

The CIAO Study

  • Insulin dosing practices in persons with diabetes on multiple daily injections

    ​This study uses an electronic dose-recording device to examine dosing in individuals on multiple daily insulin injections.

Type 1
Type 2

The TANGO Study

  • Technological Advances in Glucose Management in Older Adults

    ​This study assesses a new technology that aids the communication of health information amongst patients, family members/caregivers, and providers.

Type 1
Technology

T-Rex Study

  • Exploratory Study of CLBS03 in Children with Recent Onset T1D

    ​This study aims to assess if one's own expanded regulatory T cells can rebalance the immune system, decreasing the attack on the insulin producing cells in type 1 diabetes.

Type 1

TrialNet

  • TrialNet Natural History Study for the Prevention of Type 1 Diabetes

    The study aims to identify youth and adults at risk for type 1 diabetes by testing for diabetes-related antibodies in relatives of people with type 1 diabetes.

Type 1
At Risk

Not Recruiting


EDIC

  • Epidemiology of Diabetes Intervention and Complications

    The purpose of this study is to study the development of the major long-term complications of type 1 diabetes among the volunteers who participated in the Diabetes Control and Complication Trial (DCCT) and the first twelve years of the Epidemiology of Diabetes Interventions and Complications Study (EDIC).

Type 1

INSPIRE Study

  • Psychosocial Aspects of Artificial Pancreas Research

    This study will explore attitudes toward diabetes technology and automated insulin delivery.

Type 1
Technology

International Diabetes Closed Loop Trial

  • Clinical Acceptance of the Artificial Pancreas: The International Diabetes Closed Loop (iDCL) Trial: Research Pilot Study

    We are looking for volunteers to help us find out more about usability of a proposed automated insulin delivery system named inControl.

Type 1

MAiD

  • Monitoring Autoimmunity in Diabetes

    The purpose of the "Monitoring Autoimmunity in Diabetes" study is to look at changes in the body that may occur with the development of type 1 diabetes.

Type 1

Medalist Study

  • 50-Year Medalist Study

    The purpose of this study is to document the presence of eye, nerve and kidney complications related to diabetes, as well as to examine DNA and substances in the blood and urine of people with diabetes for 50 years or more.

Type 1

PERL Study

  • A Multi-Center Clinical Trial of Allopurinol to Prevent Renal Function (GFR) Loss in Type 1 Diabetes

    The purpose of this study is to find out whether a medication called allopurinol can prevent kidney problems, in particular the loss of kidney function, in people with type 1 diabetes.

Type 1